Skip to main content
COVID-19

Medical Policy Implementation: Vagal Nerve Blocking Therapy for Treatment of Obesity

Effective October 10, 2015, Horizon Blue Cross Blue Shield of New Jersey will change the way we consider certain claims for vagus nerve blocking therapy.

Based on the guidelines of our medical policy, Vagal Nerve Blocking Therapy for Treatment of Obesity, procedure codes 0312T, 0313T, 0314T, 0315T, 0316T or 0317T submitted on claims for services provided on and after October 10, 2015 will be denied as investigational services.

Review this revised policy in our online Medical Policy Manual.

Unless Horizon BCBSNJ gives written notice that all or part of the above changes have been cancelled or postponed, the changes will be applied to claims for services delivered on and after October 10, 2015.

CPT® is a registered mark of the American Medical Association.

Published on: July 27, 2015, 10:00 a.m. ET
Last updated on: November 24, 2020, 23:41 p.m. ET